A Study to Evaluate the Effects of a Supplement on Mucus Clearance and Respiratory Symptoms
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Change in mucus clearance
Study Overview
Brief Summary
This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of the BetterLungs Mullein + Chlorophyll supplement on mucus clearance and respiratory symptoms over 60 days. One hundred adult participants experiencing chest mucus build-up, difficulty clearing mucus, breathlessness, and low energy levels will be enrolled and randomized to either the active supplement or a matched placebo.
Participants will take their assigned product once daily in the morning mixed with water and will complete self-reported questionnaires at Baseline, Day 20, Day 40, and Day 60.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Triple (Participant, Investigator, Outcomes Assessor)
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- Yes
Inclusion Criteria
- •Be male or female
- •Be aged 18+
- •Anyone experiencing issues regarding all of the following over the past three months: a build-up of chest mucus, difficulty clearing chest mucus, breathlessness, and low energy levels
- •Anyone who is generally healthy - does not live with any uncontrolled chronic disease
- •Willing to refrain from taking any products, prescription medications, or supplements that target lung health, mucus, and energy levels during the test period
- •Willing to maintain your current diet, sleep schedule, and activity level for the duration of the study
- •Resides in the United States
- •Not currently partaking in another research study and will not be partaking in any other research study for the next 60 days and at any point during this study's duration
- •If currently taking prescription medication are willing to discuss it with their physician before participating in this study
Exclusion Criteria
- •Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including kidney disease, diabetes, cancer, mental health disorders, history of serious illness in the last three months, history of substance abuse, or planned surgery during the study period
- •Anyone who drinks heavily (i.e. 8 or more alcoholic drinks per week for women or 15 or more alcoholic drinks per week for men)
- •Anyone with a copper sensitivity disorder (such as Wilson's disease or copper metabolism disorders)
- •Anyone with kidney disease
- •Anyone with diabetes
- •Anyone with any known allergies or hypersensitivities to any supplement product ingredients
- •Anyone who is currently pregnant, trying to conceive, or breastfeeding
Outcomes
Primary Outcomes
Change in mucus clearance
Time Frame: Baseline, Day 20, Day 40, and Day 60
Self-reported change in mucus clearance assessed via questionnaire
Change in respiratory symptoms
Time Frame: Baseline, Day 20, Day 40, and Day 60
Self-reported change in respiratory symptoms assessed via questionnaire
Secondary Outcomes
- Change in perceived mucus clearance(Baseline, Day 20, Day 40, and Day 60)
- Change in energy levels(Baseline, Day 20, Day 40, and Day 60)
- Change in shortness of breath(Baseline, Day 20, Day 40, and Day 60)
- Change in breathing-related anxiety(Baseline, Day 20, Day 40, and Day 60)
- Change in ease of breathing(Baseline, Day 20, Day 40, and Day 60)
- Change in general well-being(Baseline, Day 20, Day 40, and Day 60)
